June 20, 2016 / 12:42 PM / a year ago

BRIEF-Vanc Pharma signs agreement for in-license on a CAD $150m generic molecule and soon to be off patent molecule

June 20 (Reuters) - Vanc Pharmaceuticals Signs Definitive Agreement For Exclusive In

* Vanc pharmaceuticals says entered into definitive agreement for filing two ands with exclusive marketing rights to canada from an unnamed manufacturer

* Says other product will become off patent in 2017

* License on a cad $150m generic molecule and soon to be off patent molecule Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below